PeptideDB

TC13172 2093393-05-4

TC13172 2093393-05-4

CAS No.: 2093393-05-4

TC13172 (TC-13172) is a mixed Lineage Kinase Domain-Like protein (MLKL) inhibitor with single nanomolar potency. As evid
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

TC13172 (TC-13172) is a mixed Lineage Kinase Domain-Like protein (MLKL) inhibitor with single nanomolar potency. As evidence that MLKL should be considered a druggable target, TC13172 may offer useful tools for studying the biological function of MLKL.



Physicochemical Properties


Molecular Formula C17H16N4O5S
Molecular Weight 388.397742271423
Exact Mass 390.1
Elemental Analysis C, 52.30; H, 4.65; N, 14.35; O, 20.49; S, 8.21
CAS # 2093393-05-4
Related CAS # 2093393-05-4
PubChem CID 134691750
Appearance Off-white to light yellow solid powder
LogP 0.7
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 6
Rotatable Bond Count 3
Heavy Atom Count 27
Complexity 795
Defined Atom Stereocenter Count 0
InChi Key ZTQLCNOQWGSELY-UHFFFAOYSA-N
InChi Code

InChI=1S/C17H16N4O5S/c1-19-13-14(18-16(19)27(3,25)26)21(17(24)20(2)15(13)23)9-5-7-11-6-4-8-12(22)10-11/h4,6,8,10,22H,9H2,1-3H3
Chemical Name

3-[3-(3-hydroxyphenyl)prop-2-ynyl]-1,7-dimethyl-8-methylsulfonylpurine-2,6-dione
Synonyms

2093393-05-4
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets MLKL (EC50 = 2±0.6 nM)
ln Vitro The HT-29 cell line is used to assess the anti-necroptosis potency of TC13172; the EC50 value is 20.6 nM. The inhibition potency of TC13172 against cell necroptosis is 2 nM. By firmly attaching to Cys-86, TC13172 prevents MLKL from functioning. The fact that TC13172 decreases MLKL levels in the membrane phase without affecting MLKL's phosphorylation shows that these MLKL inhibitors prevent MLKL from moving to the cell membrane and preventing necroptosis[1].
References

[1]. Discovery of a new class of highly potent necroptosis inhibitors targeting the mixed lineage kinase domain-like protein.ChemCommun (Camb). 2017 Mar 28;53(26):3637-3640.


Solubility Data


Solubility (In Vitro) DMSO: ~25 mg/mL (~64.4 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.25 mg/mL (5.79 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 22.5 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.25 mg/mL (5.79 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 22.5 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.5747 mL 12.8733 mL 25.7467 mL
5 mM 0.5149 mL 2.5747 mL 5.1493 mL
10 mM 0.2575 mL 1.2873 mL 2.5747 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.